Ellis Investment Partners, LLC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 183 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
Ellis Investment Partners, LLC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$6,0000.0%4,0000.0%0.00%0.0%
Q2 2022$6,000
-71.4%
4,000
-33.3%
0.00%
-60.0%
Q1 2022$21,000
-30.0%
6,000
-1.6%
0.01%
-28.6%
Q4 2021$30,000
+3.4%
6,100
+48.8%
0.01%0.0%
Q3 2021$29,000
-23.7%
4,1000.0%0.01%
-30.0%
Q2 2021$38,000
+100.0%
4,100
+95.2%
0.01%
+100.0%
Q1 2021$19,000
+5.6%
2,100
+5.0%
0.01%0.0%
Q4 2020$18,000
-21.7%
2,0000.0%0.01%
-37.5%
Q3 2020$23,000
+21.1%
2,000
+100.0%
0.01%
+14.3%
Q2 2020$19,0001,0000.01%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Sante Capital Fund, LP 115,637$1,072,0000.44%
Defender Capital, LLC. 135,466$1,255,0000.42%
Green Alpha Advisors, LLC 62,566$580,0000.40%
Harvest Investment Services, LLC 51,239$474,0000.20%
SEVEN EIGHT CAPITAL, LP 118,270$1,096,0000.15%
Cedar Brook Financial Partners, LLC 54,500$505,0000.15%
WASATCH ADVISORS LP 3,576,706$33,156,0000.14%
Banco BTG Pactual S.A. 20,000$185,0000.12%
Keystone Financial Group 60,712$563,0000.10%
Virtus ETF Advisers LLC 25,105$233,0000.10%
View complete list of INOVIO PHARMACEUTICALS INC shareholders